The Pharmaceutical Market: Czech Republic (pdf/xls)

The Pharmaceutical Market: Czech Republic (pdf/xls)


February 17, 2012
60 Pages - SKU: ESPI3805061
License type:
Online Download      US $1,085.00
Global Site License      US $7,095.00
Countries covered: Czech Republic

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
  • Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
  • Specialised intelligence on OTCs, generics, biologics and biosimilars.
  • Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
  • A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
  • The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.


Additional Information

THE PHARMACEUTICAL MARKET: CZECH REPUBLIC - REVIEW

The Czech Republic is the second richest country in Central & Eastern Europe in per capita terms, and the third richest in terms of total GDP. According to the Economist Intelligence Unit (EIU), the economy is expected to grow 2.0% in 2011, following increases in 2010 and 2009. Spending on healthcare is expected to rise gradually over the next few years, leading to slow growth in overall healthcare expenditure. Private expenditure will represent a quarter of the total, one of the lowest expenditures in the region.

The United States Trade Representative removed the Czech Republic from its Special 301 Watch List in 2010, due to significant progress made in border control and the introduction in January 2010 of a new criminal code which raised the maximum penalties for IPR related crimes from two to eight years imprisonment. The legal environment is generally in line with EU legislation and patent terms of 20 years are provided for product claims and pipeline protection, although the law is not retroactive. New medicines legislation, Law 115/2007, came into force in December 2007 and new regulations concerning pricing and reimbursement came into force in January 2008, bringing the system into line with the EU Transparency Directive.

The Czech Republic pharmaceutical market is the second largest in the region, twice the size of Slovakia. A moderate CAGR is expected over the 2011-2016 period. The market is driven by strong import growth. However, the economy is not expected to grow significantly in 2011 and this may temper the overall growth rate of the pharmaceutical market. Generics account for around a third of the pharmaceutical market in value terms and just over half the market in volume terms, as they are cheaper and more likely to be reimbursed.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

More Pricing reports by Espicom Healthcare Intelligence

The Worldwide Guide to Pricing & Reimbursement by Espicom Healthcare Intelligence
Provides insight into pharmaceutical pricing and reimbursement systems around the world! ...
The Pharmaceutical Market: Vietnam by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Venezuela by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: USA by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Czech Republic Pricing reports

The Pharmaceutical Market: Czech Republic by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

More Czech Republic reports

Tampons Market in Czech Republic to 2016 by Canadean Ltd
SynopsisThe report presents detailed data on consumption trends in the Tampons category in Czech Republic, analyzing consumption volumes and values. It also provides indispensable data ...
D&B Country RiskLine Report: The Czech Republic by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Perspective: Manufacturing in the Czech Republic: Industry Trends and Challenges by IDC
Czech manufacturing is in transition. Having been hit hard in the economic slowdown of 2009, it is now recovering, with current and future growth expected ...
See all reports like this >>